SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 63 filers reported holding SUNESIS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $29,000 | +3.6% | 52,822 | +0.2% | 0.00% | – |
| Q1 2016 | $28,000 | -50.9% | 52,730 | -17.6% | 0.00% | – |
| Q4 2015 | $57,000 | -41.2% | 63,982 | -46.4% | 0.00% | – |
| Q3 2015 | $97,000 | -94.3% | 119,335 | -78.9% | 0.00% | -100.0% |
| Q2 2015 | $1,704,000 | +82.4% | 566,120 | +48.5% | 0.00% | – |
| Q1 2015 | $934,000 | +195.6% | 381,237 | +207.8% | 0.00% | – |
| Q4 2014 | $316,000 | -93.0% | 123,876 | -80.4% | 0.00% | -100.0% |
| Q3 2014 | $4,520,000 | +3431.2% | 632,971 | +3116.8% | 0.00% | – |
| Q2 2014 | $128,000 | -73.3% | 19,677 | -72.8% | 0.00% | – |
| Q1 2014 | $479,000 | -61.9% | 72,472 | -72.7% | 0.00% | – |
| Q4 2013 | $1,257,000 | +1032.4% | 265,182 | +1087.0% | 0.00% | – |
| Q3 2013 | $111,000 | +42.3% | 22,340 | +48.8% | 0.00% | – |
| Q2 2013 | $78,000 | -79.8% | 15,015 | -83.7% | 0.00% | – |
| Q4 2012 | $386,000 | +160.8% | 91,840 | +247.9% | 0.00% | – |
| Q3 2012 | $148,000 | – | 26,396 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |